Stem-like ovarian cancer cells can serve as tumor vascular progenitors - Test2 - elhamkhani - TriplyDB

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

http://www.wikidata.org/entity/Q30491933

about

Tumor refractoriness to anti-VEGF therapy The NF-κB Pathway and Cancer Stem Cells Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs Differentiation and transdifferentiation potentials of cancer stem cells Reactive oxygen species in cancer stem cells Compensatory angiogenesis and tumor refractoriness Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma Current status and evolution of preclinical drug development models of epithelial ovarian cancer Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like Cells Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells Multimodality animal rotation imaging system (Mars) for in vivo detection of intraperitoneal tumors Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214.Ovulation and extra-ovarian origin of ovarian cancer Recent insights into the role of NF-kappaB in ovarian carcinogenesis.Role of liver stem cells in hepatocarcinogenesis.The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis Regulation of inflammation by the NF-κB pathway in ovarian cancer stem cells.Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells Clinical significance of side population in ovarian cancer cells.Advances in ovarian cancer screening: health and medicine for women: a multidisciplinary, evidence-based review of mid-life health concerns.Murine model for non-invasive imaging to detect and monitor ovarian cancer recurrence Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway.Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer.Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.Ovarian cancer stem cell markers: prognostic and therapeutic implications.Targeted cancer therapy--are the days of systemic chemotherapy numbered?The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis.Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence Role of the microenvironment in ovarian cancer stem cell maintenance.Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor.High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.The duplicitous origin of ovarian cancer.Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin

P2860

Q26747678-8DC684CA-A4D9-400B-9A37-818F06E1A4CA Q26750605-0425556A-2BDA-4D07-9286-D1942D1F08AA Q26777335-D3AA718F-03BB-434A-B3A6-A1F37FFB4054 Q26782242-E19391E8-521A-4CE2-A410-7A6D9AD93CD1 Q26849216-95137CF0-EDB6-4862-8AE2-D701B32259BD Q26851916-A7624605-EBA3-4B12-A45B-76B6AA4B0FA7 Q26998068-3C56313F-84C5-4090-8D90-FE98F64CCF84 Q27028117-F26AAA99-B2EE-4E24-B218-927D687C517F Q28072067-4BA8D37A-C00B-4A3A-9AEA-1C75D8DF8352 Q28543359-30CCCCE8-CF1E-4EB5-91CF-6022E53754D2 Q30541216-84324850-DF40-4C8E-AF4A-541CBEBA07FF Q30541218-B193EA26-D089-40CB-A1AB-5370213A2BDA Q30607164-0465BE04-0233-4CF5-98E7-F90F0ADEF1DC Q33557623-BBD143DB-ECA3-47BC-B3F1-3AE36359CC76 Q33761711-E2E9CF15-7C51-43B4-A92E-CA762CD6D0C4 Q33927452-B4B46BE5-66F5-48D0-B41A-F28232493244 Q34063581-80855091-D3FE-4A29-BCD1-F3BC1B72BB29 Q34152899-9B1D0A16-41B5-4061-A54A-E7BC673499FB Q34259112-3B33DEBF-6709-4B3E-887F-14A91F730E42 Q34285178-68964997-7B97-4E09-8902-333F91A78AE3 Q34365639-7A3647BD-F511-4900-8763-60C66CB8CAF5 Q34424820-F95032E7-32AF-41AD-A4FD-09A2EB4D8749 Q34483738-BE54BAC6-C42C-44CA-AB9E-BE9B270EE3C6 Q34523621-BEFCF1FA-8B0C-4BB6-A1E6-F5E50C40290C Q34634654-EF5F314F-F13B-4C58-AC02-19F4E246F54E Q34719958-0E72A439-BB84-4EEF-B517-341ABB8C6CA7 Q35158474-17FD70F9-5897-40CC-B52B-E3E9AC487504 Q35158853-6DB747B4-BD03-4E28-89EC-5213C1C1208B Q35195618-5AC550CB-B52A-4E07-A24A-23A52662B827 Q35348365-86FCC902-D552-40EB-9548-13267D96480E Q35606242-6544E6C2-279C-4B8A-A1CC-01CB6EE36A33 Q36174805-F6196B78-1AD8-43A0-BFDA-5E1D17B746C2 Q36300487-4BD5AC80-79E4-40CA-B86C-FA837A841DA8 Q36414361-18304E5A-295E-48C6-B923-F2EA422B74E4 Q36654413-5807DD84-75F0-4EDD-97FF-901E1764A3C0 Q36665179-15468B8C-68ED-441D-B848-8FDC81593648 Q36742307-2F8D2A40-A3F5-485E-A9A5-7C0D2CEBFBFC Q36791997-BBB9CC3A-1F89-4C10-9859-680D3FAC9984 Q36919484-00D36B46-C213-4BD9-9285-7B9159778368 Q36983929-F0FC53CC-ABBD-4FC9-8684-528305BF34B0

P2860

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

http://www.wikidata.org/entity/Q30491933

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

@ast

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

@en

type

label

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

@ast

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

@en

prefLabel

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

@ast

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

@en

P1433

Q30491933-3F951CD3-2D07-4A9B-B721-33AAFFD7102E

P1476

Q30491933-86A15715-40E8-481A-9658-02A50306B64B

P2093

Q30491933-1E607746-DD93-4131-8844-BF5D742B1CE0

Q30491933-28D0404E-2103-4EB3-BAA2-ED9B32E54F2B

Q30491933-4AD84E75-0E99-42C3-AE2C-02B5AC295729

Q30491933-6BD2491E-85CD-41F1-8112-4D01E99B4772

Q30491933-929C0B4B-72F4-46A0-A275-87CCE3864EF1

Q30491933-BC4D7780-AA39-4090-B781-3A4F15EDAFF8

Q30491933-CF062420-0F20-4B87-9995-7C94692ED0D4

Q30491933-D9C8ADB8-36A5-4163-BA4D-E1768266CB29

Q30491933-E60C218D-6327-4E42-B232-41B7785658FB

P2860

Q30491933-01E168AF-3891-4E53-8EE5-DC15DFCB70AC

Q30491933-0E305946-4D41-4580-B845-42D430729018

Q30491933-19D385B6-A6EF-4965-9523-87AE77CFD8FC

Q30491933-29CC060F-18FB-4B9F-BEAD-B2E2B50720C6

Q30491933-3267FC1A-AC7B-4641-B890-3D46FD80DDAF

Q30491933-48AAA52F-A4C5-4949-9458-D4F4F3B4F143

Q30491933-582A4667-E850-4ED0-911B-90057E4D437C

Q30491933-5C8C1764-5D8D-4A59-8AAD-708BC4EB1C93

Q30491933-600630A6-EB14-4D80-9CEF-E2CF42753592

Q30491933-6455A1E5-4EAF-4C44-8AD6-45D94F876D6D

P304

Q30491933-D1D7666D-B3D9-449A-BDF8-54D3BD85E007

P31

Q30491933-FA6EE4B2-C6D8-4DE1-8C74-D3568636FD5A

P356

Q30491933-2A4DEF1F-5851-4CB3-AC57-77C659665612

P433

Q30491933-DC6FBEBA-785A-4841-A325-92B4C7E983AD

P478

Q30491933-444B20BC-18C7-4C49-9F7D-50B53A865C4D

P577

Q30491933-6ED2A425-A851-43F8-AD95-5088F0400C1A

P5875

Q30491933-AF20A389-508C-4249-BB1B-439500DAB0D4

P698

Q30491933-61003E22-EE37-4108-A35D-2E9DF9B3DBD5

P921

Q30491933-CB19EB14-192B-43A9-8AD0-EF6508F7E168

P932

Q30491933-9A7FC32A-4C5C-4F93-9480-86F3B3C6AC8F

P356

P1433

P1476

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

@en

P2093

Ayesha B Alvero

http://www.w3.org/2001/XMLSchema#string

Carlos Cano Marquina

http://www.w3.org/2001/XMLSchema#string

Dan-Arin Silasi

http://www.w3.org/2001/XMLSchema#string

Gil Mor

http://www.w3.org/2001/XMLSchema#string

Han-Hsuan Fu

http://www.w3.org/2001/XMLSchema#string

Irene Visintin

http://www.w3.org/2001/XMLSchema#string

Jennie Holmberg

http://www.w3.org/2001/XMLSchema#string

Jessica Oidtman

http://www.w3.org/2001/XMLSchema#string

Liora Mor

http://www.w3.org/2001/XMLSchema#string

P2860

IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway

Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells

Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures

Angiogenesis in cancer and other diseases

Soluble endoglin contributes to the pathogenesis of preeclampsia

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

Isolation of putative progenitor endothelial cells for angiogenesis

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Tumorigenesis and the angiogenic switch

P304

2405-2413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.191

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26720318

http://www.w3.org/2001/XMLSchema#string

P698

19658191

http://www.w3.org/2001/XMLSchema#string

P921

P932

2783765

http://www.w3.org/2001/XMLSchema#string